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Abstract
Background—Lung cancer is the leading cause of cancer-related death among Chinese 
Americans. A detailed examination of incidence trends by immigration status and histology may 
inform the etiology of lung cancer in this growing population.
Methods—California Cancer Registry data were enhanced with data on patient nativity. Lung 
cancer incidence rates for Chinese males and females were computed for the years 1990–2010, 
and rates by immigration status and histology were computed for 1990–2004. Trends were 
assessed with annual percentage change (APC) statistics (two-sided P values) based on linear 
regression.
Results—A total of 8,167 lung cancers were diagnosed among California Chinese from 1990 to 
2010. Overall incidence increased nonstatistically among U.S.-born males (APC, 2.1; 95% CI, 
Corresponding Author: Scarlett Lin Gomez, Cancer Prevention Institute of California, 2201 Walnut Avenue, Suite 300, Fremont, CA 
94538. Phone: 510-608-5041; Fax: 510-608-5085; scarlett.gomez@cpic.org. 
Authors’ Contributions
Conception and design: S.L. Gomez, M. McCusker, H.A. Wakelee, C.A. Clarke
Development of methodology: S.L. Gomez, M. McCusker, C.A. Clarke
Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): S.L. Gomez, C.A. Clarke
Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): S.L. Gomez, J. Yang, I. 
Cheng, H.A. Wakelee, M. Patel, C.A. Clarke
Writing, review, and/or revision of the manuscript: S.L. Gomez, J. Yang, S.-W. Lin, M. McCusker, A. Sandler, I. Cheng, H.A. 
Wakelee, M. Patel, C.A. Clarke
Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): S.L. Gomez, C.A. 
Clarke
Study supervision: S.L. Gomez, C.A. Clarke
Note: Supplementary data for this article are available at Cancer Epidemiology, Biomarkers & Prevention Online (http://
cebp.aacrjournals.org/).
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed by the other authors.
Disclaimer
The ideas and opinions expressed in this article are those of the author(s) and endorsement by the State of California, Department of 
Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and 
Subcontractors is not intended nor should be inferred.
HHS Public Access
Author manuscript
Cancer Epidemiol Biomarkers Prev. Author manuscript; available in PMC 2017 December 
28.
Published in final edited form as:
Cancer Epidemiol Biomarkers Prev. 2015 August ; 24(8): 1157–1164. doi:
10.1158/1055-9965.EPI-15-0123.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
−4.9 to 9.7), but decreased significantly among foreign-born (APC, −1.7; 95% CI, −2.9 to −0.6). 
Statistically significant decreasing trends were observed for non–small cell lung cancer (NSCLC), 
specifically the squamous cell and large cell carcinoma subtypes among foreign-born males. 
Among females, incidence decreased nonsignificantly among U.S.-born (APC, −2.8; 95% CI, −9.1 
to 4.0) but was stable among foreign-born (APC, −0.4; 95% CI, −1.7 to 1.0). A statistically 
significant decreasing trend was observed for squamous cell among foreign-born females.
Conclusions—These data provide critical evidence base to inform screening, research, and 
public health priorities in this growing population.
Impact—Given the low smoking prevalence among Chinese Americans, especially females, and 
few known lung cancer risk factors in U.S. never-smoker populations, additional research of 
etiologic genetic or biologic factors may elucidate knowledge regarding lung cancer diagnosed in 
never smokers.
Introduction
Numbering 4.0 million, Chinese Americans are the largest Asian population in the United 
States (1). Lung cancer is the most common cause of cancer-related death (2) and the second 
and fourth most common cancer diagnosed among U.S. Chinese males and females, 
respectively (3). We recently documented overall declines in lung cancer incidence among 
Chinese American males and females from 1990 to 2010, but trends in adenocarcinoma, the 
most common histologic subtype of lung cancer, were either increasing among males 
[annual percentage change (APC) of 1.3%; 95% confidence interval (CI), 0 to 2.5 from 1996 
to 2010] or stable among females (APC, 0.3; 95% CI, −0.4 to 1.1) from 1990 to 2010); all 
other subtypes were declining over time (4). Adenocarcinoma is less strongly associated 
with tobacco smoke than small cell and squamous cell subtypes. In a meta-analysis of case–
control studies from Europe and Canada, the odds ratio (OR) for adenocarcinoma comparing 
heavy smokers with never smokers was 21.9 (95% CI, 16.6–29.0) among males and 16.8 
(9.2–30.6) among females, relative to 111.3 (69.8–177.5) for small cell lung cancer in males 
and 108.6 (50.7–232.8) for females, and 103.5 (74.8–143.2) for squamous cell lung cancer 
in males and 62.7 (31.5–124.6) for females (5). The extent to which these smoking-
associated risks differ among Chinese Americans, however, has not been well documented.
Smoking patterns among Chinese Americans vary by acculturation in opposing directions 
between males and females—smoking increases with acculturation among females but 
decreases with acculturation among males (6). In addition to smoking, acculturation may be 
associated with other lung cancer risk factors, including exposure to second-hand smoke and 
indoor and outdoor air pollution, and previous history of lung diseases (7–18). In our prior 
analysis for diagnoses from 1998 to 2002, we found generally higher incidence rates of non–
small cell lung cancer (NSCLC) among foreign-born Chinese males and females relative to 
U.S.-born, although within NSCLC histology groups, the higher incidence was statistically 
significant only for squamous cell among males (19); these associations may be due to 
higher prevalence of lung cancer risk factors among foreign-born than U.S.-born.
No studies, to our knowledge, have examined trends in the incidence of histologic subtypes 
of lung cancer among Asian Americans by immigrant status. These data are needed as they 
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may be used to inform recent U.S. Preventive Task Force (USPTF) recommendations for 
low-dose spiral computed tomography (CT) lung cancer screening for heavy smokers and 
for surveillance of this common and fatal disease among the large and growing Chinese 
American population. These data can also be useful for informing lung cancer etiology, 
particularly as Chinese females are noted to have an exceptionally high burden of lung 
cancer in light of their low reported rates of smoking; examination of trends in histology-
specific lung cancer by immigrant status can provide insights into the relative contributions 
of genetic and environmental factors. We used population-based California Cancer Registry 
data enhanced with information regarding patient nativity to examine cancer incidence 
trends among Chinese Americans. We characterized histology- and gender-specific lung 
cancer incidence trends among Chinese in California, the U.S. state with the largest Chinese 
population (1.35 million; 33.7% of the U.S. Chinese population) over a 21-year period 
(1990–2010) and by immigrant status over a 15-year period (1990–2004).
Materials and Methods
Cancer incidence data
We obtained data for all primary invasive lung cancer [International Classification of 
Diseases for Oncology, 3rd edition (ICD-O-3) site codes, C34.0–C34.9, excluding 9050–
9055, 9140, 9590–9992] occurring among California Chinese American residents during the 
period between January 1, 1990, through December 31, 2010, from the California Cancer 
Registry [CCR, comprising four registries (San Francisco Bay Area, San Jose/Monterey, Los 
Angeles, and Greater California) within the NCI Surveillance, Epidemiology, End Results 
(SEER) program]. Information on patient race/ethnicity is primarily based on data collected 
in hospital medical records and defined by self-report from patients, assumptions from 
hospital personnel, or inference from other identification information of patients, including 
race/ethnicity, maiden name, surname, birthplace (20), and death records. The study cohort 
for incidence analysis included 8,167 invasive lung cancers diagnosed in patients whose 
race/ethnicity was classified as Chinese. Other patient characteristics were also obtained 
from CCR data, including age and year of diagnosis, birthplace, gender, residential address 
and stage at diagnosis, and histologic subtype [small cell carcinoma: 8041–8045, and 8246; 
squamous cell carcinoma: 8051, 8052, 8070–8078, 8083, and 8084; adenocarcinoma: 8050, 
8140–8147, 8201, 8230, 8250–8255, 8260, 8263, 8290, 8310, 8320, 8323, 8220, 8350, 
8441, 8460, 8470, 8471, 8480, 8481, 8490, 8500, 8503, 8507, 8550, and 8570–8576; large 
cell carcinoma: 8011–8015, 8082, and 8123, and NSCLC, not otherwise specified (NSCLC, 
NOS): 8010, 8020–8022, 8030– 8035, 8046, 8094, 8120, 8130, 8170, 8200, 8240–8249, 
8340, 8430, 8525, 8551, 8560, 8562, 8580, 8940, 8972, and 8980].
As results from our prior studies showed that Asian patients in the CCR with unknown 
registry birthplace are more likely to be U.S.-born (21), random imputation of immigration 
status for cases with unknown birthplace would therefore lead to an underestimate of U.S.-
born cases. To more accurately impute immigration status, we applied a statistical 
imputation method based on the age at receipt of social security numbers (SSN; ref. 22). By 
comparing the age of SSN issue with self-reported birthplace in previously interviewed 
cancer patients (n = 1,836) and based on maximization of the area under the receiver-
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operating characteristic curve and confirmation with logistic regression modeling, patients 
receiving a SSN before age 25 years were considered U.S.-born, and those who had received 
an SSN at or after age 25 years as foreign-born. This age cutoff point resulted in 84% 
sensitivity and 80% specificity for assigning foreign-born status across the Asian 
populations. For our study, registry-based birthplace data were available for 93% of the 
Chinese cases (72% from hospital records; 21% from death certificates). The missing 
birthplace information was imputed using the method described above for about 7% of 
cases, and randomly assigned based on the overall sample’s joint distribution of race/
ethnicity, gender, age, and birthplace for the remaining <1% of cases for whom their SSNs 
were missing or invalid.
Patients’ residential address at diagnosis was geocoded and assigned to a census block 
group, which was linked to block group-level measures developed from census data. 
Neighbor-hood socioeconomic status (SES) measure is a composite index developed from 
principal component analysis, incorporating information on education, occupation, 
employment, household income, poverty, rent and house values from Census 1990 summary 
file (for cases diagnosed 1990–1995), Census 2000 Summary File (applied to cases 
diagnosed 1996–2005), and American Community Survey (ACS) 2007–2011 data (applied 
to cases diagnosed 2006–2010 as ACS replaced the decennial census long form in 2010; 
refs. 23, 24). Ethnic enclaves are neighborhoods that are ethnically distinct from its 
surrounding area and are characterized using a composite index based on four census 
indicator variables: percent recent immigrants, percent Asian/Pacific Islander (API) 
language-speaking households that were linguistically isolated, percentage of API language 
speakers with limited English proficiency, and percent API population (25). For cases 
diagnosed during the periods 1990–1995 and 1996–2005, this information was derived from 
the summary files of Census 1990 and 2000, respectively; for cases diagnosed in 2006–
2010, we applied the Census 2000 measure as the component variables are lacking or 
unreliable in the ACS. Both neighborhood SES and ethnic enclave measures were classified 
into quintiles based on distributions across California.
Population data
Population data are obtained from U.S. Census data for 1990, 2000, and 2010. Race/
ethnicity, age, and immigrant status are based on self-report—race/ethnicity and age from 
the Census short-form (1990, 2000, 2010) and immigrant status from the Census long-form 
(1990 and 2000). From census summary files, we obtained population counts by gender, 
race/ethnicity, and 5-year age group for California Chinese in censal years 1990, 2000, and 
2010. For each intercensal year between 1990 and 2010, the population counts were imputed 
by linear interpolation methods. For Chinese population estimates by immigration status, 
data from the 5% (1 in 20) Integrated Public-Use Microdata Sample (IPUMS) of the 1990 
and 2000 censuses were used to estimate the percentage of foreign-born persons, by age, for 
each gender and ethnic subgroup; population counts in censal years were imputed using the 
smooth spline function in the R statistical software package; and intercensal and postcensal 
year counts for 1990 to 2004 were computed by interpolation and extrapolation (26). 
Estimates were then adjusted to match total population estimates, by age and year, as 
provided by the California Department of Finance (for years 1988–1989) and the U.S. 
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Census (for years 1990–2004). Because of lack of population estimate data from the 2010 
Census for Chinese populations by immigration status, population denominator data were 
estimated for this study through 2004. Thus, cancer incidence rates by immigration status 
are available only through 2004.
Statistical analysis
Lung cancer histologic subtype-specific incidence rates and 95% confidence intervals (CI) 
were calculated as cases per 100,000 persons and age adjusted to the 2000 U.S. standard 
population using SEER Stat software (http://seer.cancer.gov/seer-stat/). Annual rates are 
shown graphically as trends (27), except for rates for U.S.-born by histology where 3-year 
averaged rates are shown. APC statistics (two-sided P values) using the weighted least 
squares method were used to characterize the magnitude and direction of trends (28).
Results
A total of 8,167 lung cancers were diagnosed among Chinese in California from 1990 to 
2010; the majority, 7,265 (89%), were foreign-born, 79% of whom were born in China, 
followed by 7.4% in Taiwan, 5.1% in Hong Kong, and 2.8% in Vietnam. Among males 
(Table 1), foreign-born cases were older than U.S.-born cases (74.8% of foreign-born were 
age 65 or older relative to 69% of U.S.-born cases). Relatively more foreign-born than U.S.-
born males were diagnosed in the more recent 2004–2010 time period. Both foreign-born 
and U.S.-born had a relatively high proportion of cases diagnosed as NSCLC NOS. A lower 
proportion of lung cancers among foreign-born males were diagnosed with localized stage 
(13.5%) relative to U.S.-born (17.1%); however, foreign-born had a higher proportion of 
unknown stage relative to U.S.-born (10.7% vs. 6.5%). A lower proportion of foreign-born 
than U.S.-born male cases lived in higher SES neighborhoods, while a higher proportion of 
foreign-born cases lived in higher enclave neighborhoods.
Among Chinese females (Table 2), age at diagnosis was similar to males, with a higher 
proportion of older foreign-born cases than U.S.-born cases (70.9% vs. 66.4% ages 65 or 
older). As with males, proportionally more foreign-born than U.S.-born females were 
diagnosed in the more recent 2004–2010 time period (33.1% vs. 29.9%). A lower proportion 
of foreign-born cases were diagnosed with localized stage (13.5% vs. 19.0% among U.S.-
born) and a higher proportion of foreign-born were diagnosed with distant stage (60.0% vs. 
52.6% among U.S.-born). As with Chinese male cases, proportionally more foreign-born 
female cases lived in lower SES neighborhoods and in more ethnic neighborhoods.
Among both Chinese males and females, overall lung cancer incidence rates declined 
significantly from 1990 to 2010 (−1.4% per year; 95% CI, −2.1 to −0.8 among males and 
−1.0% per year; 95% CI, −1.6 to −0.3 among females). Among males, statistically 
significant declines were observed for small cell (APC, −2.4; 95% CI, −3.8 to −0.9), 
NSCLC (APC, −1.6; 95% CI, −2.3 to −0.9), specifically, the squamous cell (APC, −4.7; 
95% CI, −5.8 to −3.7), and large cell (APC, −8.6; 95% CI, −10.5 to −6.6) carcinoma to 
subtypes [Fig. 1, Table 3; Supplementary Tables S1 (males) and S2 (females)]. Among 
females, statistically significant declines were observed for NSCLC (APC, −0.8; 95% CI, 
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−1.5 to −0.1), most notably the squamous cell carcinoma subtype (APC, −4.9; 95% CI, −6.5 
to −3.1).
By immigrant status, among males, overall incidence increased nonstatistically from 1990 to 
2004 among U.S.-born (APC, 2.1; 95% CI, −4.9 to 9.7), but decreased significantly among 
foreign-born [APC, −1.7; 95% CI, −2.9 to −0.6; Fig. 2; Table 4; Supplementary Tables S3 
(foreign-born males) and S4 (U.S.-born males)]. No significant trends were observed for any 
histologic subtype among U.S.-born males, while statistically significant decreasing trends 
were observed for NSCLC (APC, −1.7; 95% CI, −3.1 to −0.3), specifically the squamous 
cell (APC, −6.8; 95% CI, −8.1 to −5.4), and large cell carcinoma subtypes (APC, −9.0; 95% 
CI, −12.8 to −5.0) among foreign-born males. Among females, incidence decreased non-
statistically among U.S.-born (APC, −2.8; 95% CI, −9.1 to 4.0) but was stable among 
foreign-born [APC, 0.4; 95% CI, −1.7 to 1.0; Fig. 2; Table 4; Supplementary Tables S5 
(foreign-born increasing trend for NSCLC NOS (APC, 3.9; 95% CI, 0.7 to 7.1) among 
foreign-born females.
Discussion
Our analysis of 8,167 lung cancers diagnosed among Chinese Americans in California found 
divergence in trends by sex and histologic subtype. For total lung cancers among California 
Chinese males, we observed declining trends among foreign-born but a suggestion of 
increasing trends among U.S.-born, while among California Chinese females, we found 
stable rates among foreign-born but a suggestion of decreasing trends among U.S.-born.
Among foreign-born males, the significant declines for most histologies indicate the success 
of lowered tobacco use and consequently the abatement of tobacco-associated lung cancers. 
However, among U.S.-born males, nonsignificantly increasing trends for adenocarcinoma 
and NSCLC NOS subtypes is a concern and warrant further study, particularly as tobacco 
intake has been documented to decrease with acculturation among Chinese males (6, 29). 
The significant decline in squamous cell lung cancer among foreign-born females correlates 
with the temporal decline in current smoking according to the California Health Interview 
Survey data from 5.6% current smokers in 2001 to 1% in 2010–2011 (29). Using national 
SEER data spanning over a 21-year period from 1990 to 2010, we recently documented an 
increase in the rate of lung adenocarcinoma from 1996 to 2010 (1.3% per year) among 
Chinese males and stable trends among Chinese females, in contrast to statistically 
significant declining trends of other lung cancer histologic subtypes (4); however, the 
increase in the rate of adenocarcinoma among males may be due to a concomitant decrease 
in the rate of unspecified histologic subtypes (30).
Among U.S.-born Chinese females, we found a nonsignificantly declining trend for 
adenocarcinoma, although the trend was unstable due to small numbers of U.S.-born cases, 
and a flat trend among foreign-born females. Proportionally more lung cancers were 
adenocarcinomas (nearly 60%) among Chinese females than males, and among U.S.-born 
than foreign-born females, while the reverse was true among males. Of the histologies 
described here, adenocarcinoma is least closely associated with tobacco intake (5); thus, this 
pattern suggests that risk factors other than smoking may be responsible for the observed 
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lung cancer incidence trends and the majority of lung cancers among Chinese females. 
Epplein and colleagues found that Chinese American women had a 4-fold increase in risk of 
mainly adenocarcinoma and large cell carcinoma compared with that expected based on 
rates among non-Hispanic whites, after accounting for smoking status (31). Based primarily 
on data from Asia and some from Hawaii (32), the epidemiology of lung cancer appears to 
be distinctly unique among Asian females, with proportionally higher incidence of 
adenocarcinoma, and more than half of lung cancers occurring among never smokers. Some 
authors have reported a higher proportion of EGFR-TK mutations. In addition to the well-
established association with second-hand tobacco smoke, studies in east Asia have also 
identified several other risk factors for lung cancer among female never smokers, including 
exposure to indoor cooking oil fumes especially in the presence of poor ventilation, prior 
lung infections, air pollution, dietary quality and reproductive history, and interaction with 
genetic factors, including genes in the acetylation and inflammation pathway (33–37). 
However, as the prevalence of some of these exposures, including indoor and outdoor air 
pollution, is considerably less common among Asian Americans in the United States, it is 
unknown the extent to which these risk factors together explain the lung cancer incidence 
patterns among Chinese American female never smokers. Without a clear understanding of 
the etiologic factors underlying lung cancer incidence among Chinese Americans males and 
females, we are at a loss for designing the appropriate intervention strategies to reduce their 
high burden of disease. In addition, a contemporary, focused study of potential risk factors in 
such a population may provide valuable insights into the understanding of lung cancer 
etiology among never smokers, which is likely a distinct disease entity from lung cancer 
among smokers (16).
The findings may be limited by misclassification of cancer registry data on race/ethnicity, 
which are primarily derived from medical records (38, 39); however, prior research shows 
good classification accuracy for Chinese Americans (40, 41). Incidence rates may also be 
underestimated due to exclusion of cases coded by cancer registrars as “Asian, not otherwise 
specified” from the numerator. Some of the incidence rates are unstable due to small 
numbers, especially among U.S.-born. The Chinese American population is very 
heterogeneous; however, the available data do not allow us to assess incidence by country of 
origin or length of residence in the United States. Because of the lack of population 
enumeration by birthplace from the 2010 Census, we were not able to derive population 
estimates beyond 2004. Our rates may also be affected by errors associated with the 
intercensal and especially postcensal annual population estimates (42). Finally, our results 
may not be generalizable to Chinese American populations outside of California.
Despite these potential limitations, this report based on data from the CCR covering more 
than one third of the U.S. Chinese American population provides the first-ever data on 
histology-specific lung cancer trends by immigration status, serving as a critical evidence 
base to inform screening, research, and public health priorities in this growing population. 
With the recent U.S. Preventive Task Force guidelines on low-dose CT lung cancer 
screening for heavy smokers, attention should now be given to encouraging screening 
among Chinese Americans, particularly given that this group has traditionally been among 
the slowest to adopt cancer screening recommendations (43). Given the low smoking 
prevalence among Chinese Americans, especially females, and few known lung cancer risk 
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factors in U.S. never-smoker populations, additional research of etiologic genetic or biologic 
factors inherent to these populations may elucidate knowledge regarding lung cancer 
diagnosed in never smokers.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Lung cancer incidence trends among Chinese Americans, by sex and histology, California, 
1990–2010. A, males, by histology. B, females, by histology.
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Figure 2. 
Lung cancer incidence trends among Chinese Americans, by sex, nativity, and histology, 
California, 1990–2004. A, U.S.-born males, by histology; B, foreign-born males, by 
histology; C, U.S.-born females, by histology; D, foreign-born females, by histology.
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Table 1
Characteristics of male Chinese American lung cancer cases by nativity, California, 1990–2010
Characteristic
U.S.-born Chinese
(N = 491)
Foreign-born Chinese
(N = 4,321)
Age at diagnosis, y
 <50 6.9% 4.7%
 50–59 12.4% 11.1%
 60–64 11.6% 9.3%
 65–69 12.8% 14.3%
 70–74 19.3% 19.0%
 >75 36.9% 41.5%
Year of diagnosis
 1990–1995 21.4% 20.8%
 1996–2000 29.7% 20.0%
 2001–2005 23.8% 26.9%
 2006–2010 25.1% 32.3%
Histology
 Small cell carcinoma 7.3% 9.2%
 NSCLC 89.6% 85.4%
 Squamous 12.2% 17.1%
 Adenocarcinoma 46.6% 38.7%
 Large cell 4.3% 4.9%
 NSCLC, not otherwise specified 26.5% 24.7%
 Other lung cancer 3.1% 5.5%
Stage at diagnosis
 Local 17.1% 13.5%
 Regional 17.7% 19.2%
 Distant 58.7% 56.6%
 Unknown 6.5% 10.7%
Block group SESa
 Quintile 1 (low SES) 9.6% 16.5%
 Quintile 2 10.0% 17.2%
 Quintile 3 18.7% 19.2%
 Quintile 4 27.9% 23.3%
 Quintile 5 (high SES) 33.8% 23.9%
Block group ethnic enclavea
 Quintile 1 (least ethnic) 3.9% 1.2%
 Quintile 2 8.1% 2.7%
 Quintile 3 11.6% 5.6%
 Quintile 4 18.3% 12.2%
 Quintile 5 (most ethnic) 54.0% 73.4%
 Unknown 4.1% 5.0%
Cancer Epidemiol Biomarkers Prev. Author manuscript; available in PMC 2017 December 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Gomez et al. Page 14
aStatewide quintiles.
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Table 2
Characteristics of female Chinese American lung cancer cases by nativity, California, 1990–2010
Characteristic
U.S.-born Chinese
(N = 411)
Foreign-born Chinese
(N = 2,944)
Age at diagnosis, y
 <50 9.3% 7.6%
 50–59 14.8% 12.9%
 60–64 9.5% 8.6%
 65–69 14.6% 12.8%
 70–74 14.8% 15.3%
 >75 37.0% 42.8%
Year of diagnosis
 1990–1995 24.6% 18.1%
 1996–2000 18.2% 20.6%
 2001–2005 27.3% 28.2%
 2006–2010 29.9% 33.1%
Histology
 Small cell carcinoma 5.6% 3.7%
 NSCLC 91.0% 90.55%
 Squamous 8.5% 5.9%
 Adenocarcinoma 55.5% 58.7%
 Large cell 4.9% 4.77%
 NSCLC, not otherwise specified 22.1% 21.1%
 Other lung cancer 3.4% 5.8%
Stage at diagnosis
 Local 19.0% 13.5%
 Regional 21.4% 16.7%
 Distant 52.6% 60.0%
 Unknown 7.1% 9.8%
Block group SESa
 Quintile 1 (low SES) 8.0% 13.8%
 Quintile 2 8.8% 16.5%
 Quintile 3 16.5% 17.4%
 Quintile 4 25.3% 23.7%
 Quintile 5 (high SES) 41.4% 28.5%
Block group ethnic enclavea
 Quintile 1 (least ethnic) 2.7% 1.1%
 Quintile 2 6.8% 3.7%
 Quintile 3 14.6% 6.1%
 Quintile 4 15.8% 12.1%
 Quintile 5 (most ethnic) 54.0% 71.8%
 Unknown 6.1% 5.2%
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aStatewide quintiles.
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